HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Drug Office Proposal Aimed At Balancing Funds, Workload

This article was originally published in The Rose Sheet

Executive Summary

The creation of an FDA Office of Non-Prescription Products is part of a proposed reorganization of the Center for Drug Evaluation & Research Office of New Drugs seeking to balance allocation of resources with the office's workload, according to a proposal by OND Director John Jenkins, MD, released by the agency Oct. 28

You may also be interested in...



Crawford’s White House Valentine Enclosed With FDA Nomination

FDA Acting Commissioner Lester Crawford, PhD/DVM, has been nominated to fill the position permanently, the White House announced Feb. 14

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
UsernamePublicRestriction

Register

RS012574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel